on Affluent Medical (isin : FR0013333077)
Carvolix: Details on Share Capital and Voting Rights as of April 30, 2026
Carvolix, a company listed on Euronext Paris, has published figures relating to its share capital and voting rights as of April 30, 2026. With a share capital of €5,924,367.50, the company comprises 59,243,675 shares. Regarding voting rights, Carvolix has a total of 76,955,290 theoretical voting rights, while the number of exercisable voting rights is 76,908,643.
These figures comply with the requirements of Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the French Financial Markets Authority (AMF). The breakdown of voting rights reflects the distinction between theoretical and exercisable rights, each category playing a specific role in corporate governance and shareholder transparency.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news